A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin / 대한간학회지
The Korean Journal of Hepatology
; : 419-422, 2007.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-212151
Biblioteca responsável:
WPRO
ABSTRACT
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Antivirais
/
Polietilenoglicóis
/
Ribavirina
/
Pele
/
Vasculite
/
Hepatite C Crônica
/
Quimioterapia Combinada
/
Interferon alfa-2
/
Testes de Função Hepática
Limite:
Feminino
/
Humanos
Idioma:
Coreano
Revista:
The Korean Journal of Hepatology
Ano de publicação:
2007
Tipo de documento:
Artigo